Literature DB >> 18538492

Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.

Xiaojun Zhong1, Jinming Yu, Baijiang Zhang, Dianbin Mu, Weidi Zhang, Daotang Li, Anqin Han, Pingping Song, Hui Li, Guoren Yang, Feng-Ming Kong, Zheng Fu.   

Abstract

PURPOSE: To determine the optimal method of using (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) to estimate gross tumor length in esophageal carcinoma. METHODS AND MATERIALS: Thirty-six patients with esophageal squamous cell carcinoma treated with radical surgery were enrolled. Gross tumor volumes (GTVs) were delineated using three different methods: visual interpretation, standardized uptake value (SUV) 2.5, and 40% of maximum standard uptake value (SUV(max)) on FDG-PET imaging. The length of tumors on PET scan were measured and recorded as Length(vis), Length(2.5), and Length(40), respectively, and compared with the length of gross tumor in the resected specimen (Length(gross)). All PET data were reviewed again postoperatively, and the GTV was delineated using various percentages of SUV(max). The optimal-threshold SUV was generated when the length of PET matched the Length(gross).
RESULTS: The mean (+/-SD) Length(gross) was 5.48 +/- 1.98 cm. The mean Length(vis), Length(2.5), and Length(40) were 5.18 +/- 1.93 cm, 5.49 +/- 1.79 cm, and 4.34 +/- 1.54 cm, respectively. The mean Length(vis) (p = 0.123) and Length(2.5) (p = 0.957) were not significantly different from Length(gross), and Length(2.5) seems more approximate to Length(gross.) The mean Length(40) was significantly shorter than Length(gross) (p < 0.001). The mean optimal threshold was 23.81% +/- 11.29% for all tumors, and it was 19.78% +/- 8.59%, 30.92% +/- 12.28% for tumors >/=5 cm, and <5 cm, respectively (p = 0.009). The correlation coefficients of the optimal threshold were -0.802 and -0.561 with SUV(max) and Length(gross), respectively.
CONCLUSIONS: The optimal PET method to estimate the length of gross tumor varies with tumor length and SUV(max); an SUV cutoff of 2.5 provided the closest estimation in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538492     DOI: 10.1016/j.ijrobp.2008.04.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  31 in total

Review 1.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 2.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

3.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.

Authors:  Mathieu Hatt; Dimitris Visvikis; Nidal M Albarghach; Florent Tixier; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

4.  Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

Authors:  Reubendra Jeganathan; James McGuigan; Frederick Campbell; Thomas Lynch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-16       Impact factor: 9.236

5.  Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer.

Authors:  Mathieu Hatt; Dimitris Visvikis; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 6.  Application of metabolic PET imaging in radiation oncology.

Authors:  Aizhi Zhu; David M Marcus; Hui-Kuo G Shu; Hyunsuk Shim
Journal:  Radiat Res       Date:  2012-02-17       Impact factor: 2.841

7.  Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.

Authors:  Wu-Zhe Zhang; Jian-Zhou Chen; De-Rui Li; Zhi-Jian Chen; Hong Guo; Ting-Ting Zhuang; Dong-Sheng Li; Ming-Zhen Zhou; Chuang-Zhen Chen
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.

Authors:  Christophe Van de Wiele; Vibeke Kruse; Peter Smeets; Mike Sathekge; Alex Maes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

9.  Motion-compensated FDG PET/CT for oesophageal cancer.

Authors:  Francine E M Voncken; Erik Vegt; Johanna W van Sandick; Jolanda M van Dieren; Cecile Grootscholten; Annemarieke Bartels-Rutten; Steven L Takken; Jan-Jakob Sonke; Jeroen B van de Kamer; Berthe M P Aleman
Journal:  Strahlenther Onkol       Date:  2021-04-07       Impact factor: 3.621

10.  18F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy.

Authors:  Seokmo Lee; Yunseon Choi; Geumju Park; Sunmi Jo; Sun Seong Lee; Jisun Park; Hye-Kyung Shim
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.